AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Trial: 20552926
Drug: Gabapentin (up
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Gabapentin (up to 900 mg/d)
Trial: 20552926
Drug: Placebo or
RxNorm normalized name: placebo ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo or lowest dose of gabapentin (300 mg/d)
Trial: 12461037
Drug: Azithromycin administered
RxNorm normalized name: Azithromycin
DrugBank: Azithromycin (DB00207)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Azithromycin administered alone
Trial: 12461037
Drug: Ceftriaxone administered
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ceftriaxone administered alone
Trial: 12461037
Drug: Azithromycin and
RxNorm normalized name: Azithromycin
DrugBank: Azithromycin (DB00207)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Azithromycin and ceftriaxone administered concurrently
Trial: 12461037
Drug: Control arm
RxNorm normalized name: lidocaine
DrugBank: Lidocaine (DB00281)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Control arm (azithromycin and ceftriaxone administered alone)
Trial: 10656205
Drug: Calcium (500
RxNorm normalized name: calcium gluconate 45 mg calcium (500 mg) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium (500 mg b.i.d.) and 1000 IU vitamin D3
Trial: 10656205
Drug: Calcium (500
RxNorm normalized name: calcium gluconate 45 mg calcium (500 mg) ORAL TABLET
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Calcium (500 mg b.i.d.) and 1000 IU vitamin D3 with retarded-release sodium fluoride (25 mg t.i.d.)
Trial: 1888048
Drug: Epidural fentanyl
RxNorm normalized name: Fentanyl
DrugBank: Fentanyl (DB00813)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Epidural fentanyl (100 micrograms in 10 ml isotonic saline)
Trial: 18243724
Drug: Furosemide at
RxNorm normalized name: Furosemide
DrugBank: Furosemide (DB00695)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Furosemide at 4 mg/h
Trial: 18243724
Drug: Saline at
RxNorm normalized name: AT 10
DrugBank: Dihydrotachysterol (DB01070)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Saline at 2 ml/h (Control)
Trial: 10188139
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment (uvulopalatopharyngoplasty with or without mandibular osteotomy)
Trial: 6805243
Drug: 20/250 combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 20/250 combination of ethinylestradiol and levonorgestrel
Trial: 6805243
Drug: 30/250 combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30/250 combination of ethinylestradiol and levonorgestrel
Trial: 6805243
Drug: 30/150 combination
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30/150 combination of ethinylestradiol and levonorgestrel
Trial: 6805243
Drug: Triphasic drug
RxNorm normalized name: Tribasic Calcium Phosphate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Triphasic drug combination of ethinylestradiol and levonorgestrel
Trial: 17324531
Drug: Dose escalation
RxNorm normalized name: PALFORZIA Initial Dose Escalation KIT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dose escalation
Trial: 21844495
Drug: Carboplatin plus
RxNorm normalized name: Carboplatin
DrugBank: Carboplatin (DB00958)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Carboplatin plus pegylated liposomal doxorubicin (PLD) 30 mg/m²
Trial: 19659999
Drug: Rosiglitazone (4
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Rosiglitazone (4 mg day(-1) for 12 weeks)
Trial: 12145173
Drug: L-NMMA (6
FDA approved: no
EMA approved: no
PMDA approved: no
Description: L-NMMA (6 mg/kg total dose)
Trial: 2176815
Drug: 40 ml
RxNorm normalized name: hydrogen peroxide 40 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 ml 1.4% mepivacaine with epinephrine (1:200,000) and 4 mEq of NaHCO3
Trial: 2176815
Drug: 40 ml
RxNorm normalized name: hydrogen peroxide 40 ML/ML
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 ml 1.4% mepivacaine with epinephrine (1:200,000)
Trial: 7467378
Drug: K. H.
RxNorm normalized name: Ketamine Hydrochloride
FDA approved: no
EMA approved: no
PMDA approved: no
Description: K. H. 3 (medication)
Trial: 6538013
Drug: Intravenous alcohol
RxNorm normalized name: Alcohol
DrugBank: Ethanol (DB00898)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Intravenous alcohol administration
Trial: 10624640
Drug: 1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg/kg lidocaine 2% mixed with 0.5 mg/kg bupivacaine 0.5% without epinephrine (pH = 6.3)
Trial: 10624640
Drug: 1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg/kg lidocaine 2% mixed with 0.5 mg/kg bupivacaine 0.5% with 8.4% sodium bicarbonate (mean final pH = 6.90)
Trial: 10624640
Drug: 1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg/kg lidocaine 2% mixed with 0.5 mg/kg bupivacaine 0.5% with 8.4% sodium bicarbonate (mean final pH = 7.16)
Trial: 10624640
Drug: 1 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1 mg/kg lidocaine 2% mixed with 0.5 mg/kg bupivacaine 0.5% with 8.4% sodium bicarbonate (mean final pH = 7.43)
Trial: 2109497
Drug: Antidepressant with
RxNorm normalized name: Primatene with ephedrine Pill
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressant with predominant serotoninergic action (indalpine or citalopram)
Trial: 2109497
Drug: Noradrenergic antidepressant
RxNorm normalized name: Rauwolfia alkaloids, centrally acting antiadrenergic
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Noradrenergic antidepressant (maprotiline)
Trial: 29323626
Drug: Daily mood
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Daily mood chart app program (control group)
Trial: 15366587
Drug: Yigu capsule
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Yigu capsule (YGC)
Trial: 9849010
Drug: Concurrent chemo-radiotherapy
RxNorm normalized name: Chem-Star Recover
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Concurrent chemo-radiotherapy (CT + RT)
Trial: 28139220
Drug: Drug-Eluting Balloons
RxNorm normalized name: Fraxinus velutina pollen
DrugBank: Fraxinus velutina pollen (DB10455)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-Eluting Balloons (DEB) for DES-ISR
Trial: 28139220
Drug: Drug-Eluting Balloons
RxNorm normalized name: Fraxinus velutina pollen
DrugBank: Fraxinus velutina pollen (DB10455)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Drug-Eluting Balloons (DEB) for BMS-ISR
Trial: 16629894
Drug: Enzymatic commercial
RxNorm normalized name: hydrolyzed sericin (enzymatic; 2500 MW)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enzymatic commercial solution (Ortoform)
Trial: 11411816
Drug: Ziprasidone treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ziprasidone treatment
Trial: 18293201
Drug: MgSO(4) continuous
RxNorm normalized name: Ivy Dry Super Continuous Spray
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MgSO(4) continuous infusion for 24 hours postpartum (Group A)
Trial: 18293201
Drug: MgSO(4) administration
RxNorm normalized name: polidocanol
DrugBank: Polidocanol (DB06811)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: MgSO(4) administration discontinued when urinary output was > or =100 ml/hr for 2 consecutive hours (Group B)
Trial: 6342959
Drug: Metronidazole suppositories
RxNorm normalized name: metronidazole Rectal Suppository
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Metronidazole suppositories (short-term use for 72 hours)
Trial: 21164546
Drug: β‐glucan (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: β‐glucan (100 mg, Imunoglukan) supplementation
Trial: 7845115
Drug: Single course
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Single course of portal infusion with mitomycin (10 mg/m2, one dose) plus fluorouracil (500 mg/m2 per 24 h for 7 days)
Trial: 2140842
Drug: Dim light
RxNorm normalized name: kaolin light
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Dim light therapy (50 lux)
Trial: 30572281
Drug: Ultrasound-guided platelet-rich
RxNorm normalized name: platelet glycoprotein VI
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ultrasound-guided platelet-rich plasma (PRP) injection
Trial: 23344509
Drug: Pregabalin 600
RxNorm normalized name: Pregabalin
DrugBank: Pregabalin (DB00230)
FDA approved: yes
EMA approved: yes
PMDA approved: no
Description: Pregabalin 600 mg per os divided in two doses
Trial: 17376305
Drug: Combination therapy
RxNorm normalized name: REGN10933+REGN10987 combination therapy
DrugBank: Anti-SARS-CoV-2 REGN-COV2 (DB15691)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination therapy with terazosin 2 mg once daily and tolterodine 2 mg twice daily for 6 weeks
Trial: 17376305
Drug: Terazosin 2
RxNorm normalized name: terazosin 2 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terazosin 2 mg once daily for 6 weeks
Trial: 15264729
Drug: Crystalloid coload
RxNorm normalized name: influenza B virus B/Colorado/06/2017 antigen
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crystalloid coload (20 ml x kg(‐1) of crystalloid solution by rapid infusion immediately after induction)
Trial: 15264729
Drug: Crystalloid preload
RxNorm normalized name: Crystal ammonia
DrugBank: Ammonium carbonate (DB15926)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Crystalloid preload (20 ml x kg(‐1) of crystalloid solution during 20 minutes prior to induction)
Trial: 522637
Drug: Oxprenolol 40
RxNorm normalized name: oxprenolol 40 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oxprenolol 40 mg
Trial: 30829017
Drug: Antidepressant drug
RxNorm normalized name: MAO A Inhibitors, antidepressant drugs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressant drug use in PES group (n=3, 4.1%)
Trial: 30829017
Drug: Antidepressant drug
RxNorm normalized name: MAO A Inhibitors, antidepressant drugs
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Antidepressant drug use in non-PES non-glaucoma group (n=21, 1.1%)
Trial: 30829017
Drug: Medications for
RxNorm normalized name: Medicated Shampoo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medications for hypertension in PES group
Trial: 30829017
Drug: Medications for
RxNorm normalized name: Medicated Shampoo
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Medications for coronary artery disease in PES group
Trial: 24460655
Drug: Deferasirox (9.7
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Deferasirox (9.7 ± 3.0 mg/kg/d)
Trial: 21187622
Drug: 1.23% APF
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 1.23% APF gel iontophoresis
Trial: 9684120
Drug: High-dose branched
RxNorm normalized name: Machilus thunbergii branch extract
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose branched chain amino acid-enriched solution
Trial: 7601179
Drug: Nimesulide (100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Nimesulide (100 mg bid)
Trial: 7601179
Drug: Naproxen sodium
RxNorm normalized name: Naproxen Sodium
DrugBank: Naproxen (DB00788)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Naproxen sodium (550 mg bid)
Trial: 28041917
Drug: Cognitive Behavioral
RxNorm normalized name: Mahana Parallel Digital Cognitive Behavioral Therapy Mobile Application for Irritable Bowel Syndrome
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cognitive Behavioral Therapy (CBT) combined with Vocational Rehabilitation (VR)
Trial: 22923150
Drug: Micro dose
RxNorm normalized name: Lipantil Micro
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Micro dose GnRH agonist protocol
Trial: 14695934
Drug: 30 mg
RxNorm normalized name: agar 30 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 mg coenzyme Q10
Trial: 14695934
Drug: 100 mg
RxNorm normalized name: urea 100 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 100 mg coenzyme Q10
Trial: 10955324
Drug: DR4/1 peptide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DR4/1 peptide injections every 6 weeks
Trial: 10955324
Drug: DR4/1 peptide
FDA approved: no
EMA approved: no
PMDA approved: no
Description: DR4/1 peptide injections every 8 weeks
Trial: 8617186
Drug: 40 g
RxNorm normalized name: PEG-40 GLYCERYL STEARATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 g lactitol in milk chocolate
Trial: 8617186
Drug: 30 g
RxNorm normalized name: Lancet Unilet 30 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 g isomalt in milk chocolate
Trial: 8617186
Drug: 40 g
RxNorm normalized name: PEG-40 GLYCERYL STEARATE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 40 g maltitol in milk chocolate
Trial: 8617186
Drug: 30 g
RxNorm normalized name: Lancet Unilet 30 g
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 30 g maltitol in milk chocolate
Trial: 8339411
Drug: 75 mg
RxNorm normalized name: talc 75 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 75 mg flosequinan twice daily
Trial: 23981504
Drug: Topical microemulsion
RxNorm normalized name: cyclosporine microemulsion
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Topical microemulsion
Trial: 11044499
Drug: Surgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Surgical treatment (rollerball or resection)
Trial: 20443731
Drug: Q‐TER(®), 160
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Q‐TER(®), 160 mg, once a day for 30 days
Trial: 20443731
Drug: Vitamin E,
RxNorm normalized name: GRx Vitamin E, topical cream
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Vitamin E, 50 mg, once a day for 30 days
Trial: 10509550
Drug: Felodipine-metoprolol combination
RxNorm normalized name: felodipine / metoprolol
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Felodipine-metoprolol combination tablet (Logimax), 5/50 mg daily
Trial: 10509550
Drug: Enalapril, 10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Enalapril, 10 mg daily
Trial: 1563195
Drug: Temperature measurement
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Temperature measurement (AUC calculated from rectal temperature measurements one to four times a day)
Trial: 4077506
Drug: Group treatment
RxNorm normalized name: Allergenic Extracts Intradermal Kit [9 SO. GRASS GROUP TREATMENT SET]
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Group treatment with the duo formula (12 sessions over 3 months)
Trial: 31484661
Drug: Cellphone-based daily
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cellphone-based daily medication and weekly pill refilling reminders in addition to usual care
Trial: 30134283
Drug: 0.6 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.6 mg/kg oxycodone alone (Group C)
Trial: 30134283
Drug: 0.6 mg/kg
FDA approved: no
EMA approved: no
PMDA approved: no
Description: 0.6 mg/kg oxycodone + 2.4 μg/kg DEX (Group D1)
Trial: 26659543
Drug: GHB 35
RxNorm normalized name: GHB
DrugBank: gamma-Hydroxybutyric acid (DB01440)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GHB 35 mg kg(‐1)
Trial: 24115072
Drug: ONO-5334 sustained
RxNorm normalized name: ONO-5334
DrugBank: ONO-5334 (DB19206)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ONO-5334 sustained release tablet (SRT)
Trial: 24115072
Drug: ONO-5334 immediate
RxNorm normalized name: ONO-5334
DrugBank: ONO-5334 (DB19206)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: ONO-5334 immediate release tablet (IRT)
Trial: 23047652
Drug: Pomegranate extract
RxNorm normalized name: Pomegranate Extract
DrugBank: Pomegranate (DB14317)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Pomegranate extract (1-g capsule)
Trial: 29861448
Drug: MAG-DHA (8
FDA approved: no
EMA approved: no
PMDA approved: no
Description: MAG-DHA (8 × 625 mg softgels daily for 60 days)
Trial: 26758884
Drug: Tiotropium (TIO)
DrugBank: Tiotropium (DB01409)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Tiotropium (TIO) 18 µg once daily
Trial: 26758884
Drug: Aclidinium (ACL)
DrugBank: Aclidinium (DB08897)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Aclidinium (ACL) 322 µg twice daily
Trial: 7617806
Drug: Fluoxetine (40
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Fluoxetine (40 mg daily)
Trial: 31479306
Drug: Low-dose tamoxifen
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose tamoxifen
Trial: 23743969
Drug: Guayakí Yerba
RxNorm normalized name: Hyperici herba
DrugBank: St. John's Wort (DB01323)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Guayakí Yerba Maté Organic Energy Shot™ (YM; 140 mg caffeine)
Trial: 23743969
Drug: Red Bull
RxNorm normalized name: acid red 35
DrugBank: Pantothenic acid (DB01783)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Red Bull Energy Shot™ (RB; 80 mg caffeine)
Trial: 23743969
Drug: Placebo (PLA;
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Placebo (PLA; 0 mg caffeine)
Trial: 10867984
Drug: mecamylamine (20
FDA approved: no
EMA approved: no
PMDA approved: no
Description: mecamylamine (20 mg PO)
Trial: 6866592
Drug: Methylphenidate HCl
RxNorm normalized name: methylphenidate HCl
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylphenidate HCl (Ritalin) administered intravenously or orally with breakfast
Trial: 6866592
Drug: Methylphenidate HCl
RxNorm normalized name: methylphenidate HCl
DrugBank: Methylphenidate (DB00422)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Methylphenidate HCl (Ritalin) administered intravenously or orally in a fasted state
Trial: 15849207
Drug: Pethidine 20
RxNorm normalized name: Pethidine
DrugBank: Meperidine (DB00454)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Pethidine 20 mg (Group P)
Trial: 15816573
Drug: Ketamine 0.5
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Ketamine 0.5 mg kg(‐1) (Group K)
Trial: 12221161
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of highest voltage with narrowest pulse width
Trial: 10458252
Drug: CJ‐11,974 100
FDA approved: no
EMA approved: no
PMDA approved: no
Description: CJ‐11,974 100 mg
Trial: 7798528
Drug: Etilefrine (10
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Etilefrine (10 mg three times a day)
Trial: 2086821
Drug: Combination of
RxNorm normalized name: combination of rauwolfia alkaloids and diuretics incl. other combinations
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Combination of AZT and CMZ or PIPC for Escherichia coli infections
Trial: 25884315
Drug: Carbohydrate (CHO)
RxNorm normalized name: pyrrolidone carboxylate
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Carbohydrate (CHO) supplementation (1.2 g.kg(‐1) body mass.h(‐1) in a 20% CHO solution)
Trial: 25884315
Drug: Caffeine (CAF)
RxNorm normalized name: Caffeine
DrugBank: Caffeine (DB00201)
FDA approved: yes
EMA approved: no
PMDA approved: no
Description: Caffeine (CAF) supplementation (6 mg.kg(‐1) body mass)
Trial: 23665888
Drug: No preventive
FDA approved: no
EMA approved: no
PMDA approved: no
Description: No preventive care (routine medical treatment)
Trial: 21819189
Drug: Endovascular treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Endovascular treatment (coil placement)
Trial: 21819189
Drug: Neurosurgical treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Neurosurgical treatment (clip occlusion)
Trial: 19135345
Drug: Oral vinpocetine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Oral vinpocetine (VP) 30 mg for 3 months
Trial: 15472176
Drug: GH at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH at 25.0 microg/kg x d (pediatric dose)
Trial: 15472176
Drug: GH at
RxNorm normalized name: rose bengal AT
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH at 12.5 microg/kg x d (adult dose)
Trial: 10487666
Drug: GH treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: GH treatment (both doses)
Trial: 15472176
Drug: Control (no
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Control (no GH treatment)
Trial: 11549829
Drug: Lansoprazole (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole (30 mg twice daily), Amoxycillin (1000 mg twice daily), Clarithromycin (500 mg twice daily) for 14 days (LAC)
Trial: 11549829
Drug: Lansoprazole (30
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Lansoprazole (30 mg four times daily), Bismuth subsalicylate (2 tablets four times daily), Metronidazole (250 mg four times daily), Tetracycline (250 mg four times daily) for 14 days (LBMT)
Trial: 8111257
Drug: Low total
RxNorm normalized name: Colgate Total Mouthwash
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Low total fat diet (8% saturated fat, approximately 200 mg/day cholesterol)
Trial: 8111257
Drug: High unsaturated
RxNorm normalized name: high-density polyethylene
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High unsaturated fat diet (8% saturated fat, approximately 200 mg/day cholesterol)
Trial: 2888424
Drug: Terfenadine 60
RxNorm normalized name: terfenadine 60 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Terfenadine 60 mg
Trial: 2569997
Drug: Clemastine 1
RxNorm normalized name: clemastine 1 MG
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Clemastine 1 mg
Trial: 26521106
Drug: Cyclosporine A
RxNorm normalized name: CycloSPORINE A
DrugBank: Cyclosporine (DB00091)
FDA approved: no
EMA approved: no
PMDA approved: no
Description: Cyclosporine A (CYA) combined with low-dose corticosteroids (CS)
Trial: 26521106
Drug: Cyclophosphamide (CPA)
DrugBank: Cyclophosphamide (DB00531)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Cyclophosphamide (CPA) combined with low-dose corticosteroids (CS)
Trial: 12651203
Drug: favourable response
RxNorm normalized name: Besponsa
DrugBank: Inotuzumab ozogamicin (DB05889)
FDA approved: yes
EMA approved: yes
PMDA approved: yes
Description: favourable response to salvage therapy
Trial: 12651203
Drug: no specific
RxNorm normalized name: Oregano specific IgE
FDA approved: no
EMA approved: no
PMDA approved: no
Description: no specific therapy
Trial: 1576095
Drug: Low-dose nisoldipine
RxNorm normalized name: ethinyl estradiol
DrugBank: Ethinylestradiol (DB00977)
FDA approved: yes
EMA approved: no
PMDA approved: yes
Description: Low-dose nisoldipine (2 micrograms/kg) as a single intravenous injection over a 3-minute period
Trial: 1576095
Drug: High-dose nisoldipine
FDA approved: no
EMA approved: no
PMDA approved: no
Description: High-dose nisoldipine (double the low dose)
Trial: 24576886
Drug: PACK-CXL treatment
RxNorm normalized name: Hongo Killer Treatment
FDA approved: no
EMA approved: no
PMDA approved: no
Description: PACK-CXL treatment in addition to antimicrobial therapy